Abstract
The use of intravitreal corticosteroids in the management of macular oedema has recently gained widespread acceptance. New long-acting steroid preparations and methods of delivery have facilitated the use of these new modalities. This review describes the various types of macular oedema for which this therapeutic option is used and the results.
MeSH terms
-
Dexamethasone / therapeutic use
-
Fluocinolone Acetonide / therapeutic use
-
Glucocorticoids / therapeutic use*
-
Humans
-
Inflammation / complications
-
Injections
-
Macular Edema / drug therapy*
-
Macular Edema / etiology
-
Retinal Vein Occlusion / complications
-
Triamcinolone Acetonide / therapeutic use
-
Vitreous Body / drug effects
Substances
-
Glucocorticoids
-
Fluocinolone Acetonide
-
Dexamethasone
-
Triamcinolone Acetonide